Chang Zhang, PhD

Dr. Zhang received his PhD in Biochemistry and Molecular Biology in 2020 from Shanghai Institute for Biological Science, Chinese Academy of Science(CAS) and then joined Institute of Neuroscience of CAS to start his postdoctoral training in YANG HUI lab. His PhD training is focusing on liver cancer and postdoctoral training is focusing on CRISPR tools for disease therapy. From January 2022, Chang joined Müschen lab and decided to employ mouse genetics and the use of genome editing tools (CRISPR-Cas9) towards the development of pre-clinical models to investigate the mechanisms of B-cell development and leukemogenesis.